Avid Bioservices Inc expected to post earnings of 3 cents a share - Earnings Preview

Avid Bioservices

26/11/2021 21:11

* Avid Bioservices Inc  CDMO.OQ   CDMO.O  is expected to show a
rise in quarterly revenue when it reports  results on November
30 (estimated). 
* The Tustin California-based  company is expected to report  a
14.0% increase in revenue to $24.023 million from $21.06 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Avid Bioservices Inc is
for earnings of 3 cents per share. For the same quarter last
year, the company reported earnings of 1 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Avid
Bioservices Inc is $28.5​, about 10.8% below​ its last closing
price of $31.57. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jul. 31 2021  0.04        0.04       0.10      Beat    166.7
 Apr. 30 2021  0.00        0.01       -0.04     Missed  -900
 Jan. 31 2021  -0.03       -0.03      0.01      Beat    133.3​
 Oct. 31 2020  -0.05       -0.06      0.01      Beat    117.6
 ​​Jul.        -0.07       -0.07      0.06      Beat    180
 31 2020                                                
 Apr. 30 2020  -0.17       -0.16      -0.11     Beat    32.7​
 Jan. 31 2020  -0.04       -0.04      -0.06     Missed  -57.9
 Oct. 31 2019  -0.07       -0.05      -0.03     Beat    42.3
 This summary was machine generated November 26 at 21:11 GMT. 
All figures in US dollars  unless otherwise stated